Millipore Sigma Vibrant Logo

385920 HSP90 Inhibitor, CCT018159 - CAS 171009-07-7 - Calbiochem

The HSP90 Inhibitor, CCT018159, also referenced under CAS 171009-07-7, controls the biological activity of HSP90.

HSP90 Inhibitor, CCT018159 - CAS 171009-07-7 - Calbiochem: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: 4-(4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-methyl-1H-pyrazol-3-yl)-6-ethylresorcinol

View This Product on Sigma-Aldrich
385920
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
171009-07-7C₂₀H₂₀N₂O₄

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
385920-5MGCN
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 樹脂ｱﾝﾌﾟﾙ 5 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewA cell-permeable pyrazoloresorcinol compound that inhibits HSP90 ATPase activity (IC50 = 3.2 µM and 6.6 µM against human HSP90β and yeast HSP90, respectively) by targeting the enzyme's N-terminal ATP binding site. It exhibits no detectable effects against human Hsp70 or topoisomerase II even at concentrations as high as 100 µM and inhibits a panel of 20 commonly studied kinases only at much higher concentrations. Unlike 17-AAG (Cat. No. 100068), the antitumor activity of CCT018159 is not affected by the expression of NQ01/DT-diaphorase or P-glycoprotein.
      Catalogue Number385920
      Brand Family Calbiochem®
      Synonyms4-(4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-methyl-1H-pyrazol-3-yl)-6-ethylresorcinol
      References
      ReferencesHardcastle, A., et al. 2007. Mol. Cancer Ther. 6, 1112.
      Sharp, S.Y., et al. 2007. Cancer Res. 67, 2206.
      Smith, N.F., et al. 2006. Mol. Cancer Ther. 5, 1628.
      Dymock, B.W., et al. 2005. J. Med. Chem. 48, 4212.
      Cheung, K.M., et al. 2005. Bioorg. Med. Chem. Lett. 15, 3338.
      Product Information
      CAS number171009-07-7
      FormWhite solid
      Hill FormulaC₂₀H₂₀N₂O₄
      Chemical formulaC₂₀H₂₀N₂O₄
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 36/37/38

      Irritating to eyes, respiratory system and skin.
      S PhraseS: 24/25-36/37/39

      Avoid contact with skin and eyes.
      Wear suitable protective clothing, gloves and eye/face protection.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Irritant
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solution are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      385920-5MGCN 04055977189841

      Documentation

      HSP90 Inhibitor, CCT018159 - CAS 171009-07-7 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      HSP90 Inhibitor, CCT018159 - CAS 171009-07-7 - Calbiochem 試験成績書（CoA）

      タイトルロット番号
      385920

      参考資料

      参考資料の概要
      Hardcastle, A., et al. 2007. Mol. Cancer Ther. 6, 1112.
      Sharp, S.Y., et al. 2007. Cancer Res. 67, 2206.
      Smith, N.F., et al. 2006. Mol. Cancer Ther. 5, 1628.
      Dymock, B.W., et al. 2005. J. Med. Chem. 48, 4212.
      Cheung, K.M., et al. 2005. Bioorg. Med. Chem. Lett. 15, 3338.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision06-March-2008 JSW
      Synonyms4-(4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-methyl-1H-pyrazol-3-yl)-6-ethylresorcinol
      DescriptionA cell-permeable pyrazoloresorcinol compound that inhibits HSP90 ATPase activity (IC50 = 3.2 µM and 6.6 µM against human HSP90β and yeast HSP90, respectively) by targeting the enzyme's N-terminal ATP binding site. It exhibits no detectable effects against human Hsp70 or topoisomerase II even at concentrations as high as 100 µM and inhibits a panel of 20 commonly studied kinases only at much higher concentrations. Unlike 17-AAG (Cat. No. 100068), the antitumor activity of CCT018159 is not affected by the expression of NQ01/DT-diaphorase or P-glycoprotein.
      FormWhite solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number171009-07-7
      Chemical formulaC₂₀H₂₀N₂O₄
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (35 mg/ml), H₂O (1.7 mg/ml) or Ethanol (35 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solution are stable for up to 3 months at -20°C.
      Toxicity Irritant
      ReferencesHardcastle, A., et al. 2007. Mol. Cancer Ther. 6, 1112.
      Sharp, S.Y., et al. 2007. Cancer Res. 67, 2206.
      Smith, N.F., et al. 2006. Mol. Cancer Ther. 5, 1628.
      Dymock, B.W., et al. 2005. J. Med. Chem. 48, 4212.
      Cheung, K.M., et al. 2005. Bioorg. Med. Chem. Lett. 15, 3338.